Skip to main content

BD Sells $750M in Notes

NEW YORK (GenomeWeb News) – Becton Dickinson has sold $750 million worth of new notes and intends to use the proceeds to repay outstanding notes, contribute to its pension plan, and for general corporate purposes, which may include acquisitions.

The firm sold $500 million worth of 5 percent notes due May 15, 2019, and it sold $250 million worth of notes due May 15, 2039. After underwriting discounts and commissions, BD estimated that its net proceeds would be around $738 million.

Goldman Sachs and Morgan Stanley acted as representatives for several underwriters listed in the firm's prospectus.

In Wednesday afternoon trade on the New York Stock Exchange, BD's shares were up 1 percent at $65.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.